(Q72318341)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

1

D C Cattran

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

author name string

C Greenwood

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

S Ritchie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

K Bernstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

D N Churchill

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

W F Clark

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

P A Morrin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

S Lavoie

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

language of work or name

English

0 references

publication date

1 April 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

1130-1135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1995.161

25 October 2019

exact match

0 references

cites work

Idiopathic membranous nephropathy: The natural history of untreated patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

A controlled study of short-term prednisone treatment in adults with membranous nephropathy. Collaborative Study of the Adult Idiopathic Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Controlled trial of cyclophosphamide in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Controlled Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy with deteriorating renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Long-Term Benefits of Therapy With Cyclophosphamide and Prednisone in Patients With Membranous Glomerulonephritis and Impaired Renal Function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Short-term responsiveness of membranous glomerulopathy to cyclosporine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

IDIOPATHIC NEPHROTIC SYNDROME IN ADULTS. A STUDY AND CLASSIFICATION BASED ON RENAL BIOPSIES

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Membranous nephropathy: predictors of terminal renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Limitations of creatinine as a filtration marker in glomerulopathic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

In defense of creatinine clearance

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Enalapril Can Treat the Proteinuria of Membranous Glomerulonephritis Without Detriment to Systemic or Renal Hemodynamics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Cyclophosphamide provides no additional benefit to steroid therapy in the treatment of idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Membranous nephropathy--still a treatment dilemma.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Idiopathic membranous nephropathy--to treat or not to treat?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1995.161

7 January 2021

Identifiers

DOI

10.1038/KI.1995.161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7783410%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference